DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
about
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.
P2860
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@ast
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en-gb
type
label
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@ast
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en-gb
prefLabel
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@ast
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en-gb
P2093
P2860
P50
P356
P1433
P1476
DNA-mediated adjuvant immunoth ...... models of myeloid malignancies
@en
P2093
Carole Le Pogam
Elena Bernasconi
Flore Sicre
Laura Guerenne
Maria-Elena Noguera
Marie-Helene Schlageter
Marika Pla
Martine Chopin
Nader Omidvar
P2860
P304
32494-32508
P356
10.18632/ONCOTARGET.5572
P407
P577
2015-09-10T00:00:00Z